http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04159222-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbaa419ab205179f7c68e258fe4fd869
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 1990-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9af7047e0981913cb0acfde05ed6ee1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8593d1fe89dd3c143393c0f228f62a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0246059633ecb982b1741d2a674ce25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a28cdb291383f1d5c4b060080f9c6cdd
publicationDate 1992-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04159222-A
titleOfInvention Production of solid preparation for oral administration
abstract PURPOSE: To obtain a solid drug for oral administration having properly adjusted absorption and immediate effects or prolonged effects, readily being taken, comprising a drug active compound and silicon dioxide or magnesium aluminate metasilicate. n CONSTITUTION: A solid or liquid drug active compound (e.g. nifedipine) suitable for oral administration is dissolved in an organic solvent (e.g. ethanol). The solution is blended with fine powder of silicon dioxide or magnesium aluminate metasilicate and generally used preparation auxiliaries such as excipient, binder, disintegrator or dispersant properly and granulated or compression molded to give the objective substance. The weight ratio of the drug active compound and silicon dioxide or magnesium aluminate metasilicate is 1:0.5-5 by weight ratio. n COPYRIGHT: (C)1992,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010106043-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-4416001-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009524675-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003504331-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011148813-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100389750-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009113522-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4841092-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005023222-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010092925-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005082503-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9078811-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1962361-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102083467-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004045586-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1962361-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007063936-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4575654-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007179997-A
priorityDate 1990-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453678473

Total number of triples: 49.